PL3658132T3 - Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases - Google Patents

Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases

Info

Publication number: PL3658132T3
Authority: PL; Poland
Prior art keywords: compositions; treatment; amino acids; related diseases; mitochondrial dysfunction
Prior art date: 2017-07-28

Application number

PL18753465.6T

Other languages

Polish (pl)

Inventor

Paolo Luca Maria Giorgetti

Original Assignee

Professional Dietetics S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-07-28

Filing date

2018-07-20

Publication date

2022-08-01

2018-07-20 Application filed by Professional Dietetics S.P.A. filed Critical Professional Dietetics S.P.A.

2022-08-01 Publication of PL3658132T3 publication Critical patent/PL3658132T3/en

Links

150000001413 amino acids Chemical class 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000004065 mitochondrial dysfunction Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

PL18753465.6T 2017-07-28 2018-07-20 Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases PL3658132T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT102017000087359A IT201700087359A1 (en)	2017-07-28	2017-07-28	COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION
PCT/IB2018/055425 WO2019021135A1 (en)	2017-07-28	2018-07-20	Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases

Publications (1)

Publication Number	Publication Date
PL3658132T3 true PL3658132T3 (en)	2022-08-01

Family

ID=60628070

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL18753465.6T PL3658132T3 (en)	2017-07-28	2018-07-20	Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
PL21174744.9T PL3915553T3 (en)	2017-07-28	2018-07-20	Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related neurodegenerative diseases

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL21174744.9T PL3915553T3 (en)	2017-07-28	2018-07-20	Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related neurodegenerative diseases

Country Status (22)

Country	Link
US (2)	US11337946B2 (en)
EP (2)	EP3658132B1 (en)
JP (2)	JP7266767B2 (en)
KR (3)	KR20240063205A (en)
CN (1)	CN110996935A (en)
AU (2)	AU2018306540B2 (en)
BR (1)	BR112020001471A2 (en)
CA (1)	CA3070197C (en)
CL (1)	CL2020000220A1 (en)
DK (2)	DK3658132T3 (en)
ES (2)	ES3031608T3 (en)
HU (1)	HUE059050T2 (en)
IT (1)	IT201700087359A1 (en)
LT (1)	LT3658132T (en)
MX (2)	MX395240B (en)
MY (1)	MY200975A (en)
PH (1)	PH12020500190A1 (en)
PL (2)	PL3658132T3 (en)
PT (2)	PT3915553T (en)
RS (1)	RS63422B1 (en)
SG (1)	SG11201912103TA (en)
WO (1)	WO2019021135A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT201700087376A1 (en)	2017-07-28	2019-01-28	Professional Dietetics Spa	COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION
IT201700087359A1 (en) *	2017-07-28	2019-01-28	Professional Dietetics Spa	COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION
IT201800006725A1 (en)	2018-06-27	2019-12-27		COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE PREVENTION AND TREATMENT OF LIVER DISEASES
IT201900002109A1 (en) *	2019-02-13	2020-08-13	Professional Dietetics Spa	COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE TREATMENT OF INJURIES OF THE CENTRAL NERVOUS SYSTEM
JP2021038147A (en) *	2019-08-30	2021-03-11	国立大学法人鹿児島大学	Mitochondrial biosynthesis promoter
IT202000000454A1 (en) *	2020-01-13	2021-07-13	Professional Dietetics Spa	COMPOSITIONS INCLUDING AMINO ACIDS FOR THE PREVENTION AND TREATMENT OF CANCER
IT202000000442A1 (en)	2020-01-13	2021-07-13	Professional Dietetics Spa	COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE PREVENTION AND TREATMENT OF SIDE EFFECTS OF CHEMOTHERAPY
WO2021198400A1 (en) *	2020-04-01	2021-10-07	Société des Produits Nestlé S.A.	Compositions containing amino acids and methods of using such compositions for treating sarcopenia
IT202000021664A1 (en) *	2020-09-14	2022-03-14	Iaf Network S P A	BALANCED AMINO ACID FORMULATION
TW202308604A (en) *	2021-05-10	2023-03-01	國立大學法人東北大學	Composition for increasing muscle mass
IT202100029726A1 (en)	2021-11-24	2023-05-24	Professional Dietetics Spa	OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF CORNEAL LESIONS
KR20250035239A (en)	2023-09-05	2025-03-12	메디컬아이피 주식회사	Method and apparatus for detecting diameter of tubular structure in medical image
CN120661636A (en) *	2025-06-12	2025-09-19	中国医学科学院医学实验动物研究所	Gene delivery system for expressing PPM1K specifically and preparation method and application thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1032403B1 (en) *	1997-10-24	2012-05-02	John P. Blass	Nutritional supplement for cerebral metabolic insufficiencies
DE10000577A1 (en)	2000-01-10	2001-07-26	Fumapharm Ag Muri	Treating mitochondrial diseases, e.g. Parkinson's or Alzheimer's disease or retinitis pigmentosa, using fumaric acid derivative, e.g. mono- or dialkyl fumarate, having succinate dehydrogenase stimulating activity
ITTO20010580A1 (en) *	2001-06-15	2002-12-15	Professional Dietetics Srl	AMINO ACID BASED COMPOSITIONS FOR IMPROVING THE MYOCARDIC VENTRICULAR FUNCTION IN PATIENTS WITH DIABETES.
ITTO20010804A1 (en)	2001-08-08	2003-02-08	Professional Dietetics Srl	COMPOSITIONS BASED ON AMINO ACIDS, SUITABLE FOR THERAPY FOR CICATRIZATION AND / OR REPAIR OF INJURIES AND INJURIES, IN PARTICULAR FOR THE APP
US6620850B2 (en)	2001-09-19	2003-09-16	University Of Florida	Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
US20060063827A1 (en) *	2004-09-23	2006-03-23	Yu Ruey J	Systemic administration of therapeutic amino acids and N-acetylamino acids
ITTO20030789A1 (en)	2003-10-07	2005-04-08	Professional Dietetics Srl	COMPOSITION BASED ON AMINO ACIDS FOR TREATMENT
WO2007049818A1 (en)	2005-10-27	2007-05-03	Ajinomoto Co., Inc.	Anti-fatty liver, anti-obesity or hypolipidemic composition
US7982066B2 (en) *	2005-12-09	2011-07-19	Novalife, Inc.	High protein supplement
JP2007161642A (en)	2005-12-14	2007-06-28	Kyowa Hakko Kogyo Co Ltd	Alcoholic liver injury inhibitor
KR101919747B1 (en)	2011-02-17	2018-11-20	각꼬호우진 구루메 다이가쿠	Potentiator of antitumor activity of chemotherapeutic agent
WO2012147901A1 (en)	2011-04-28	2012-11-01	味の素株式会社	Composition for mitigating anticancer drug side effects
US20130084378A1 (en)	2011-09-30	2013-04-04	Daesang Corporation	Amino acid seasoning compositions comprising l-glutamic acid and l-lysine
US9198454B2 (en)	2012-03-08	2015-12-01	Nusirt Sciences, Inc.	Compositions, methods, and kits for regulating energy metabolism
WO2013188874A1 (en)	2012-06-15	2013-12-19	Gencia Corporation	Methods of mitigating side effects of radiation exposure and chemotherapy
CN102772407B (en)	2012-08-01	2014-09-17	岳茂兴	Pharmaceutical composition for promoting nerve damage restoration and application thereof
US9597367B2 (en) *	2013-04-19	2017-03-21	Bioventures, Llc	Methods for improving muscle and heart function
US10226441B2 (en)	2014-12-09	2019-03-12	Nihon Sizen Hakkoh Co., Ltd.	Aging inhibitor
MX357998B (en) *	2015-03-20	2018-07-11	Antonio Hernandez Miramontes Jorge	A mixture of carboxylic acids, more specifically, citric acid, succinic acid, fumaric acid, malic acid, and their use for the treatment of patients with chronic renal failure, acute renal failure, acute or chronic hepatopathies associated with hyperamonemia, congenital diseases with enzymatic alterations in the urea cycle, as well as clinical conditions associated with a negative nitrogen balance.
WO2016179657A1 (en) *	2015-05-11	2016-11-17	Newcastle Innovation Limited	Amino acid supplementation
EP3294279B1 (en)	2015-05-14	2020-01-01	Professional Dietetics S.p.A.	Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
WO2017020121A1 (en)	2015-07-31	2017-02-09	Val-Chum, Limited Partnership	Glycerol-3-phosphate phosphatase activators
RU2741637C2 (en)	2015-11-27	2021-01-28	Даблгуд Аб	Food additive and composition for treating metabolic syndrome
WO2018201024A1 (en)	2017-04-28	2018-11-01	Axcella Health Inc.	Amino acid compositions and their use for the treatment of traumatic brain injury
IT201700087359A1 (en)	2017-07-28	2019-01-28	Professional Dietetics Spa	COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION
IT201700087376A1 (en)	2017-07-28	2019-01-28	Professional Dietetics Spa	COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION
EP3691628A1 (en)	2017-10-02	2020-08-12	University of Florida Research Foundation, Incorporated	Materials and methods for inhibiting tumor growth
CN111867575B (en) *	2018-03-05	2023-09-29	味之素株式会社	Compositions for improving cognitive function, compositions for improving anxiety-like symptoms, and compositions for inhibiting brain atrophy
IT201800006725A1 (en)	2018-06-27	2019-12-27		COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE PREVENTION AND TREATMENT OF LIVER DISEASES
IT201900002109A1 (en)	2019-02-13	2020-08-13	Professional Dietetics Spa	COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE TREATMENT OF INJURIES OF THE CENTRAL NERVOUS SYSTEM
US12137359B2 (en)	2019-11-11	2024-11-05	Lg Electronics Inc.	Vehicular distributed antenna system operating in wireless communication system and method for operating same
IT202000000442A1 (en)	2020-01-13	2021-07-13	Professional Dietetics Spa	COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE PREVENTION AND TREATMENT OF SIDE EFFECTS OF CHEMOTHERAPY
IT202000000454A1 (en)	2020-01-13	2021-07-13	Professional Dietetics Spa	COMPOSITIONS INCLUDING AMINO ACIDS FOR THE PREVENTION AND TREATMENT OF CANCER
WO2022266480A1 (en)	2021-06-17	2022-12-22	Axcella Health Inc.	Methods of predicting liver fat content and uses thereof

2017
- 2017-07-28 IT IT102017000087359A patent/IT201700087359A1/en unknown
2018
- 2018-07-20 US US16/634,330 patent/US11337946B2/en active Active
- 2018-07-20 KR KR1020247014645A patent/KR20240063205A/en not_active Ceased
- 2018-07-20 PL PL18753465.6T patent/PL3658132T3/en unknown
- 2018-07-20 DK DK18753465.6T patent/DK3658132T3/en active
- 2018-07-20 SG SG11201912103TA patent/SG11201912103TA/en unknown
- 2018-07-20 KR KR1020237026054A patent/KR20230117642A/en not_active Ceased
- 2018-07-20 CA CA3070197A patent/CA3070197C/en active Active
- 2018-07-20 EP EP18753465.6A patent/EP3658132B1/en active Active
- 2018-07-20 HU HUE18753465A patent/HUE059050T2/en unknown
- 2018-07-20 WO PCT/IB2018/055425 patent/WO2019021135A1/en not_active Ceased
- 2018-07-20 PT PT211747449T patent/PT3915553T/en unknown
- 2018-07-20 CN CN201880047542.0A patent/CN110996935A/en active Pending
- 2018-07-20 ES ES21174744T patent/ES3031608T3/en active Active
- 2018-07-20 RS RS20220627A patent/RS63422B1/en unknown
- 2018-07-20 KR KR1020207003492A patent/KR102566297B1/en active Active
- 2018-07-20 MY MYPI2020000106A patent/MY200975A/en unknown
- 2018-07-20 LT LTEPPCT/IB2018/055425T patent/LT3658132T/en unknown
- 2018-07-20 DK DK21174744.9T patent/DK3915553T3/en active
- 2018-07-20 EP EP21174744.9A patent/EP3915553B1/en active Active
- 2018-07-20 MX MX2020001083A patent/MX395240B/en unknown
- 2018-07-20 ES ES18753465T patent/ES2923126T3/en active Active
- 2018-07-20 JP JP2019566579A patent/JP7266767B2/en active Active
- 2018-07-20 BR BR112020001471-0A patent/BR112020001471A2/en unknown
- 2018-07-20 AU AU2018306540A patent/AU2018306540B2/en active Active
- 2018-07-20 PT PT187534656T patent/PT3658132T/en unknown
- 2018-07-20 PL PL21174744.9T patent/PL3915553T3/en unknown
2020
- 2020-01-27 MX MX2022010774A patent/MX2022010774A/en unknown
- 2020-01-27 PH PH12020500190A patent/PH12020500190A1/en unknown
- 2020-01-27 CL CL2020000220A patent/CL2020000220A1/en unknown
2022
- 2022-04-20 US US17/724,537 patent/US11957651B2/en active Active
2023
- 2023-03-08 JP JP2023035509A patent/JP7513311B2/en active Active
- 2023-11-14 AU AU2023266256A patent/AU2023266256B2/en active Active

Also Published As

Publication number	Publication date
NZ761073A (en)	2025-02-28
ES2923126T3 (en)	2022-09-23
CA3070197C (en)	2025-07-08
PT3658132T (en)	2022-07-08
US20220249418A1 (en)	2022-08-11
KR20230117642A (en)	2023-08-08
MY200975A (en)	2024-01-27
PL3915553T3 (en)	2025-08-04
PH12020500190A1 (en)	2020-09-28
LT3658132T (en)	2022-07-25
RU2019141152A (en)	2021-08-30
US11957651B2 (en)	2024-04-16
AU2023266256B2 (en)	2025-01-23
JP7513311B2 (en)	2024-07-09
DK3658132T3 (en)	2022-07-04
CA3070197A1 (en)	2019-01-31
ES3031608T3 (en)	2025-07-09
EP3915553B1 (en)	2025-03-26
HUE059050T2 (en)	2022-10-28
WO2019021135A1 (en)	2019-01-31
BR112020001471A2 (en)	2020-09-15
MX395240B (en)	2025-03-25
CN110996935A (en)	2020-04-10
JP2020528400A (en)	2020-09-24
US11337946B2 (en)	2022-05-24
EP3658132A1 (en)	2020-06-03
KR20240063205A (en)	2024-05-09
AU2018306540B2 (en)	2023-11-30
KR20200033872A (en)	2020-03-30
RU2770660C2 (en)	2022-04-20
JP2023071939A (en)	2023-05-23
EP3915553A1 (en)	2021-12-01
SG11201912103TA (en)	2020-01-30
DK3915553T3 (en)	2025-06-23
MX2020001083A (en)	2022-08-31
RU2019141152A3 (en)	2021-09-10
JP7266767B2 (en)	2023-05-01
AU2023266256A1 (en)	2023-12-07
AU2018306540A1 (en)	2020-02-20
CL2020000220A1 (en)	2020-07-31
PT3915553T (en)	2025-06-23
RS63422B1 (en)	2022-08-31
EP3658132B1 (en)	2022-04-13
US20200230093A1 (en)	2020-07-23
IT201700087359A1 (en)	2019-01-28
MX2022010774A (en)	2023-02-23
KR102566297B1 (en)	2023-08-10

Publication	Publication Date	Title
SG11201912103TA (en)	2020-01-30	Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
IL284371A (en)	2021-07-29	Amino acid compositions and methods for the treatment of liver diseases
IL273959A (en)	2020-05-31	Methods and compositions for the treatment of rare diseases
IL256085B (en)	2021-02-28	A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment
IL272336A (en)	2020-03-31	Amino acid compositions for the treatment of neuronal injury
PL3577135T3 (en)	2023-12-04	A pharmaceutical composition for use in the treatment or prevention of c5-related diseases
IL274578A (en)	2020-06-30	Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
ZA202007834B (en)	2021-10-27	Compositions comprising amino acids for use in the prevention and treatment of liver diseases
SG11201912098SA (en)	2020-01-30	Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
PL3294279T3 (en)	2020-06-29	Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
IL272495A (en)	2020-03-31	Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
IL265911A (en)	2019-06-30	Apilimod compositions and methods for using same in the treatment of alzheimer's disease
IL280389A (en)	2021-03-01	A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment
SMT202100070T1 (en)	2021-03-15	Complex and compositions for the treatment of ophthalmic and dermatological diseases
GB201410869D0 (en)	2014-07-30	Novel pharmaceutical formulations and their use in the treatment of periodontal disease
ZA201801945B (en)	2023-11-29	Compositions and methods for the treatment of parkinson's disease
GB201603510D0 (en)	2016-04-13	Compositions for use in the treatment of neurological disease
GB201718838D0 (en)	2017-12-27	Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
GB201817346D0 (en)	2018-12-12	Compounds and pharmaceutical compositions thereof for use in the treatment of diseases
GB201712742D0 (en)	2017-09-20	Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
HK40036525A (en)	2021-05-28	Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
HK40030474A (en)	2021-02-26	Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
HK40023899A (en)	2020-12-04	Amino acid compositions and their use for the treatment of traumatic brain injury
IL243402A0 (en)	2016-03-31	Methods of identifying compositions which can be used in the treatment of heart diseases and uses of such compounds in the treatment of same
HK1242961A1 (en)	2018-07-06	Protective metallothionein analog compounds, their compositions and use thereof in the treatment of pathogenic diseases